This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Korner, J. Articles by Chua, S. C. Search for Related Content PubMed PubMed Citation Articles by Korner, J. Articles by Chua, S. C., Jr.

Effects of Leptin Receptor Mutation on Agrp Gene Expression in Fed and Fasted Lean and Obese (LA/N-fa^f) Rats¹

Departments of Medicine (J.K., S.L.W., S.-M.L., I.M.C., R.L.L., S.C.C.) and Pediatrics (S.-M.L., R.L.L., S.C.C.), Columbia University College of Physicians & Surgeons, New York, New York 10032

Address all correspondence and requests for reprints to: Judith Korner M.D., Ph.D., Department of Medicine, Division of Endocrinology, Columbia University College of Physicians & Surgeons, 630 West 168th Street, Black Building Room 905, New York, New York 10032. E-mail: jk181{at}columbia.edu

Agouti-related protein provides an orexigenic signal, probably through interaction with central melanocortin receptors. Expression of Agrp is markedly increased in the hypothalamus of mice deficient in leptin (Lep^ob/Lep^ob) or its receptor (Lepr^db/Lepr^db), suggesting that leptin mediates signals suppressing Agouti-related protein production. The regulation of Agrp expression in the rat hypothalamus has not been reported. We, therefore, analyzed the expression of Agrp in the medial basal hypothalamus of lean (+/+, +/fa^f) and obese leptin receptor-deficient (fa^f/fa^f) LA/N rats. Using a sensitive solution hybridization/S1 nuclease protection assay, we found no significant difference in Agrp messenger RNA (mRNA) levels (pg/µg total RNA ± SEM) in obese rats (n = 5), compared with lean controls (n = 5): 0.46 ± 0.06 vs. 0.47 ± 0.06 (P = 0.9). Similarly, no difference in Agrp expression was found using in situ hybridization or semiquantitative RT-PCR. In contrast to Agrp, Pomc mRNA levels were significantly suppressed in the obese, compared with the lean, rats (P = 0.001). Thus, the ratio of Pomc to Agrp mRNA is decreased in the obese rats and may be an important modulator of food intake. To assess the physiological regulation of Agrp in rats, we examined the effect of food deprivation in lean Sprague Dawley (SD) rats. There was a 273% increase in medial basal hypothalamus Agrp mRNA in SD rats fasted for 48 h (n = 8), compared with rats fed ad libitum (n = 8): 0.82 ± 0.23 vs. 0.30 ± 0.08 (P = 0.0001). Lean LA/N rats (n = 7) fasted for 48 h also showed a 231% increase in Agrp expression, compared with fed lean controls (n = 8): 0.74 ± 0.11 vs. 0.32 ± 0.03 (P = 0.002), whereas Pomc expression was decreased by 32% in fasted animals from the same experiment (0.34 ± 0.05 vs. 0.50 ± 0.07; P = 0.03). There were no significant differences in Agrp or Pomc mRNA levels between fasted and fed obese LA/N-fa^f rats. These results suggest that, in the rat, the Agrp response to fasting may involve leptin-mediated phenomena, but factors in addition to leptin must also be involved in the regulation of Agrp gene expression.

This article has been cited by other articles:

				G. Ramadori, C. E. Lee, A. L. Bookout, S. Lee, K. W. Williams, J. Anderson, J. K. Elmquist, and R. Coppari Brain SIRT1: Anatomical Distribution and Regulation by Energy Availability J. Neurosci., October 1, 2008; 28(40): 9989 - 9996. [Abstract] [Full Text] [PDF]

				V. Tolle and M. J. Low In Vivo Evidence for Inverse Agonism of Agouti-Related Peptide in the Central Nervous System of Proopiomelanocortin-Deficient Mice Diabetes, January 1, 2008; 57(1): 86 - 94. [Abstract] [Full Text] [PDF]

				M. Goto, H. Arima, M. Watanabe, M. Hayashi, R. Banno, I. Sato, H. Nagasaki, and Y. Oiso Ghrelin Increases Neuropeptide Y and Agouti-Related Peptide Gene Expression in the Arcuate Nucleus in Rat Hypothalamic Organotypic Cultures Endocrinology, November 1, 2006; 147(11): 5102 - 5109. [Abstract] [Full Text] [PDF]

				C. D. Morrison, G. J. Morton, K. D. Niswender, R. W. Gelling, and M. W. Schwartz Leptin inhibits hypothalamic Npy and Agrp gene expression via a mechanism that requires phosphatidylinositol 3-OH-kinase signaling Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E1051 - E1057. [Abstract] [Full Text] [PDF]

				R G P Denis, C Bing, S Brocklehurst, J A Harrold, R G Vernon, and G Williams Diurnal changes in hypothalamic neuropeptide and SOCS-3 expression: effects of lactation and relationship with serum leptin and food intake J. Endocrinol., October 1, 2004; 183(1): 173 - 181. [Abstract] [Full Text] [PDF]

				K. Baran, E. Preston, D. Wilks, G. J. Cooney, E. W. Kraegen, and A. Sainsbury Chronic Central Melanocortin-4 Receptor Antagonism and Central Neuropeptide-Y Infusion in Rats Produce Increased Adiposity by Divergent Pathways Diabetes, January 1, 2002; 51(1): 152 - 158. [Abstract] [Full Text] [PDF]

				J. J. Hwa, L. Ghibaudi, J. Gao, and E. M. Parker Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R444 - R451. [Abstract] [Full Text] [PDF]

				C. Fekete, J. Kelly, E. Mihaly, S. Sarkar, W. M. Rand, G. Legradi, C. H. Emerson, and R. M. Lechan Neuropeptide Y Has a Central Inhibitory Action on the Hypothalamic-Pituitary-Thyroid Axis Endocrinology, June 1, 2001; 142(6): 2606 - 2613. [Abstract] [Full Text] [PDF]